Dr. Duma is the Associate Director of the Cancer Care Equity Program and a thoracic oncologist at Dana-Farber Cancer Institute.

Dr. Duma's clinical interests include the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine.

Matthew P. Smeltzer, PhD, MStat, is an Associate Professor of Epidemiology and Biostatistics and University Research Professor at the University of Memphis School of Public Health. His primary research interests include clinical epidemiology, applied biostatistics, and implementation science in lung cancer and sickle cell disease. He is active in the International Association for the Study of Lung Cancer (IASLC) and currently serves on the IASLC Communications Committee. His lung cancer research focuses on quality of surgical care, molecular testing, staging, and early detection. Dr. Smeltzer has more than 100 peer-reviewed publications and is an Accredited Professional Statistician (American Statistical Association). He enjoys teaching epidemiologic methods and mentoring doctoral students.